GE HealthCare Technologies Inc. $GEHC Shares Sold by Resona Asset Management Co. Ltd.

Resona Asset Management Co. Ltd. cut its stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 5.8% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 138,110 shares of the company’s stock after selling 8,499 shares during the period. Resona Asset Management Co. Ltd.’s holdings in GE HealthCare Technologies were worth $11,355,000 at the end of the most recent reporting period.

Other institutional investors have also recently added to or reduced their stakes in the company. Temasek Holdings Private Ltd acquired a new stake in GE HealthCare Technologies in the third quarter valued at $99,922,000. Locust Wood Capital Advisers LLC raised its holdings in shares of GE HealthCare Technologies by 7.1% during the third quarter. Locust Wood Capital Advisers LLC now owns 2,084,337 shares of the company’s stock worth $156,534,000 after purchasing an additional 137,992 shares during the period. Nan Fung Trinity HK Ltd. acquired a new stake in shares of GE HealthCare Technologies during the third quarter worth $23,206,000. Envestnet Asset Management Inc. raised its holdings in shares of GE HealthCare Technologies by 15.8% during the third quarter. Envestnet Asset Management Inc. now owns 338,914 shares of the company’s stock worth $25,452,000 after purchasing an additional 46,231 shares during the period. Finally, Sound Shore Management Inc CT raised its holdings in shares of GE HealthCare Technologies by 14.6% during the third quarter. Sound Shore Management Inc CT now owns 980,756 shares of the company’s stock worth $73,655,000 after purchasing an additional 125,062 shares during the period. 82.06% of the stock is owned by institutional investors and hedge funds.

Insider Transactions at GE HealthCare Technologies

In related news, insider Frank R. Jimenez bought 1,750 shares of the firm’s stock in a transaction that occurred on Thursday, April 30th. The stock was purchased at an average price of $60.45 per share, for a total transaction of $105,787.50. Following the transaction, the insider directly owned 93,932 shares of the company’s stock, valued at approximately $5,678,189.40. This represents a 1.90% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, CFO James Saccaro acquired 3,310 shares of GE HealthCare Technologies stock in a transaction dated Friday, May 1st. The shares were acquired at an average price of $60.60 per share, with a total value of $200,586.00. Following the transaction, the chief financial officer owned 87,471 shares in the company, valued at approximately $5,300,742.60. This represents a 3.93% increase in their position. The disclosure for this purchase is available in the SEC filing. Insiders have purchased a total of 11,847 shares of company stock worth $719,555 over the last ninety days. Insiders own 0.36% of the company’s stock.

GE HealthCare Technologies Stock Performance

Shares of GEHC opened at $64.26 on Thursday. The firm has a 50-day moving average price of $68.79 and a 200 day moving average price of $76.40. The firm has a market capitalization of $29.23 billion, a PE ratio of 15.37, a P/E/G ratio of 1.39 and a beta of 0.74. The company has a quick ratio of 0.95, a current ratio of 1.22 and a debt-to-equity ratio of 0.95. GE HealthCare Technologies Inc. has a 52-week low of $58.75 and a 52-week high of $89.77.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its earnings results on Wednesday, April 29th. The company reported $0.99 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.07 by ($0.08). The company had revenue of $5.13 billion during the quarter, compared to the consensus estimate of $5.04 billion. GE HealthCare Technologies had a net margin of 9.10% and a return on equity of 20.46%. The business’s quarterly revenue was up 7.4% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.01 EPS. GE HealthCare Technologies has set its FY 2026 guidance at 4.800-5.000 EPS. On average, sell-side analysts anticipate that GE HealthCare Technologies Inc. will post 4.89 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of brokerages have weighed in on GEHC. Wall Street Zen cut shares of GE HealthCare Technologies from a “buy” rating to a “hold” rating in a report on Saturday, March 21st. Morgan Stanley increased their target price on shares of GE HealthCare Technologies from $80.00 to $85.00 and gave the stock an “equal weight” rating in a report on Wednesday, February 4th. Weiss Ratings cut shares of GE HealthCare Technologies from a “hold (c)” rating to a “hold (c-)” rating in a report on Friday, May 15th. Jefferies Financial Group dropped their target price on shares of GE HealthCare Technologies from $105.00 to $90.00 in a report on Thursday, April 30th. Finally, Barclays lowered their price target on shares of GE HealthCare Technologies from $87.00 to $78.00 and set an “equal weight” rating for the company in a research report on Thursday, April 30th. Nine investment analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company’s stock. According to MarketBeat.com, GE HealthCare Technologies currently has an average rating of “Moderate Buy” and an average target price of $80.21.

GE HealthCare Technologies Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.